Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

17
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
17
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

15
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
15
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

16
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Safety profile of dual TIGIT and PD-L1 blockade with tiragolumab plus atezolizumab in solid tumors: a systematic review and meta-analysis of randomized controlled trials.

Expert opinion on drug safety·2026
Same author

AI-enabled length of stay forecasting reduces variability and improves operational efficiency in paediatric surgical capacity management.

Evidence-based nursing·2026
Same author

Unraveling the link: A systematic review and meta analysis of acute respiratory distress syndrome and delirium.

Respiratory medicine·2026
Same author

Safety and Efficacy of Iron Chelators in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Improving AI literacy reduces anxiety and enhances nurses' acceptance of AI.

Evidence-based nursing·2026
Same author

Are higher autism rates in FNAIT without intracranial haemorrhage real or a result of increased screening?

Evidence-based nursing·2026

相关实验视频

Updated: Jul 16, 2025

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.2K

人工智能在增强同步管理中的作用 - - 一个更新.

Alifiya Aamir1, Yumna Jamil1, Maham Bilal1

  • 1Dow University of Health Sciences, Karachi, Pakistan.

Current problems in cardiology
|September 16, 2023
PubMed
概括

人工智能 (AI) 可以通过改善诊断和风险分层来增强昏迷管理. 数据和伦理方面的挑战需要合作,才能成功地将AI整合到医疗保健中.

更多相关视频

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K
A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients
05:01

A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients

Published on: October 17, 2017

7.1K

相关实验视频

Last Updated: Jul 16, 2025

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

17.2K
Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
06:51

Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device

Published on: July 29, 2016

8.0K
A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients
05:01

A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients

Published on: October 17, 2017

7.1K

科学领域:

  • 医疗信息学 医疗信息学
  • 心脏病学 心脏病学
  • 人工智能的人工智能

背景情况:

  • 昏迷是由于大脑血液流量减少而暂时失去意识的症状,这给诊断和管理带来了挑战.
  • 它日益蔓延和相关的医疗保健成本需要创新的解决方案.
  • 目前诊断和风险分层的的方法可能是复杂的和资源密集的.

研究的目的:

  • 审查人工智能 (AI) 在昏迷管理中的应用.
  • 探索AI在改善昏迷诊断,风险评估和患者护理方面的潜力.
  • 在将人工智能集成到同步管理中识别挑战和伦理考虑.

主要方法:

  • 对现有AI应用文献的综述.
  • 分析机器学习技术,特别是人工神经网络,用于风险分层.
  • 对人工智能驱动的临床决策支持工具进行审查.

主要成果:

  • 人工智能在区分昏迷症状和提高风险分层精度方面显示出潜力.
  • 人工神经网络显示出对精确的风险评估有前途.
  • 由人工智能驱动的工具可以优化患者评估和医疗保健资源分配.

结论:

  • 人工智能为改善昏迷患者的结果和医疗保健效率提供了重大前景.
  • 解决数据质量,阶级不平衡和道德问题对于AI实施至关重要.
  • 跨学科的合作对于成功地将人工智能集成到 syncope 管理中至关重要.